JOSHUA ROESSER: Open Payments
NPI 1376016766 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 6 companies in 2025. Trend: 2023 $146 · 2024 $123 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: ABILIFY ASIMTUFII, UZEDY, VIVITROL, ABILIFY MAINTENA, INVEGA SUSTENNA, VRAYLAR, ARISTADA, COBENFY.
Industry payments across UT — which companies pay providers there.
